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ARTICLE
Wnt signaling controls pro-regenerative Collagen
XII in functional spinal cord regeneration in
zebraﬁsh
Daniel Wehner 1, Themistoklis M. Tsarouchas1, Andria Michael1, Christa Haase2, Gilbert Weidinger 3,
Michell M. Reimer4, Thomas Becker1 & Catherina G. Becker1
The inhibitory extracellular matrix in a spinal lesion site is a major impediment to axonal
regeneration in mammals. In contrast, the extracellular matrix in zebraﬁsh allows substantial
axon re-growth, leading to recovery of movement. However, little is known about regulation
and composition of the growth-promoting extracellular matrix. Here we demonstrate that
activity of the Wnt/β-catenin pathway in ﬁbroblast-like cells in the lesion site is pivotal for
axon re-growth and functional recovery. Wnt/β-catenin signaling induces expression of
col12a1a/b and deposition of Collagen XII, which is necessary for axons to actively navigate
the non-neural lesion site environment. Overexpression of col12a1a rescues the effects
of Wnt/β-catenin pathway inhibition and is sufﬁcient to accelerate regeneration. We
demonstrate that in a vertebrate of high regenerative capacity, Wnt/β-catenin signaling
controls the composition of the lesion site extracellular matrix and we identify Collagen XII as
a promoter of axonal regeneration. These ﬁndings imply that the Wnt/β-catenin pathway and
Collagen XII may be targets for extracellular matrix manipulations in non-regenerating
species.
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After a spinal injury, non-neural cells invade the lesion siteand set up a complex extracellular matrix (ECM)1, 2. Thelesion site ECM consists of a plethora of molecules that
may be inhibitory, permissive, or promoting for axon re-growth.
In mammals, the balance of ECM molecules is shifted towards an
inhibitory matrix that does not allow axons to cross the lesion
site, in turn preventing recovery of function1, 2. In vertebrates
capable of functional spinal cord regeneration, such as ﬁshes
and salamanders, the lesion site ECM naturally allows crossing
of regenerating axons, offering potential insight into how this
ECM is controlled and which ECM molecules may promote
regeneration3–6.
A candidate to control the composition of the lesion site ECM
in zebraﬁsh is the Wnt/β-catenin pathway, because Wnt/β-cate-
nin signaling has been shown to control ﬁbroblast biology
and ECM deposition7–10. Moreover, axonal reconnection,
which is necessary for functional recovery in adult11 and larval
zebraﬁsh12, 13, also depends on Wnt/β-catenin pathway activity in
both systems14, 15. Wnt/β-catenin signaling involves extracellular
Wnt ligand-induced stabilization and translocation of β-catenin
into the nucleus where it modiﬁes target gene transcription
together with Tcf/Lef family proteins16. To understand how Wnt/
β-catenin signaling promotes spinal cord regeneration, cell
types of action and downstream mechanisms of pathway activa-
tion, such as deposition of ECM factors, need to be identiﬁed.
Different ECM molecules have speciﬁc functions for axon
growth and regeneration. For example, among the collagens,
col19a1, col18a1, and col15a1b promote growth of developing
motor axons, whereas only col4a5 is necessary for the correct
growth of regenerating motor axons in zebraﬁsh17–20. Hence, it is
important to identify speciﬁc axon re-growth-promoting ECM
components in the lesion site.
Adult and larval zebraﬁsh show robust axonal and functional
regeneration after complete spinal cord transection11–13, 21.
Importantly, axon regeneration in larvae is rapid and can be
observed in real-time. Lesion-induced paralysis at 3 days-post
fertilization (dpf) is followed by recovery of touch-evoked
swimming within 2 days post-lesion (dpl)13. Swimming capa-
city is lost upon re-transection15, 16. This makes zebraﬁsh larvae a
powerful tool to identify mechanisms responsible for establishing
a lesion environment that is conducive to axon growth. Moreover,
sensitive reporter lines and inducible cell-type speciﬁc pathway
inhibition using the TetON system can be used to interrogate the
Wnt/β-catenin signaling pathway in zebraﬁsh22–25.
Here, we ﬁnd that Wnt/β-catenin signaling in ﬁbroblast-like
cells accumulating in the lesion site is pivotal for axon re-growth
and functional regeneration. A gene expression screen
identiﬁes col12a1a/b expression and deposition of Collagen XII
downstream of Wnt/β-catenin signaling to be required for
regeneration. Hence, Wnt/β-catenin signaling in non-neural cells
controls the composition of an axon-growth promoting ECM
environment in the spinal lesion site in zebraﬁsh.
Results
Axonal bridging correlates with functional recovery. To
identify molecular mechanisms regulating the spinal lesion ECM,
we ﬁrst analysed dynamics of axon regeneration in zebraﬁsh
larvae. Using anti-acetylated Tubulin immunohistochemistry we
observed little to no axonal re-growth within the ﬁrst 12 h after a
spinal lesion. At 12 h post-lesion (hpl) mainly axonal debris,
indicated by fragmented anti-acetylated Tubulin immunor-
eactivity, and only very few and thin re-growing axon fascicles
were found in the lesion site (5/20 animals; Supplementary
Fig. 1a). We found no animals with a completely bridged lesion
site (0/20 animals). Analysis of stills from time-lapse video
microscopy imaging at this time point conﬁrmed little axonal re-
growth (2/9 animals with axons in the lesion site, 0/9 animals
with axonal bridge; Supplementary Movies 1 and 2). After this
initial lag phase axons rapidly re-grew (Supplementary Fig. 1a).
At 1 dpl, 57% of all larvae showed axonal bridging of the lesion
site, as indicated by continuous axonal labelling between rostral
and caudal spinal cord (n= 112). Bridging further increased to
>80% of the animals at 2 dpl (n= 111; Fig. 1c). Remarkably, we
found that in the 18% of lesioned larvae in which no axonal
bridge was established by 2 dpl, functional recovery, as measured
by touch-evoked swim distance, was also impaired (analysed in
Xla.Tubb:DsRED26 transgenic ﬁsh; Supplementary Fig. 1b,c).
This underscores the importance of axonal re-growth for
functional recovery in larvae.
Axons navigate a non-neural lesion site that is rich in ECM. To
determine how axons cross the lesion site, we analysed their
relationship with astroglia-like processes, as these have been
shown to be supportive for axon regeneration in zebraﬁsh27, 28.
We imaged axonal and glial processes in time-lapse video
microscopy using double transgenic ﬁsh for Xla.Tubb:DsRED, to
visualize neuronal processes, and either gfap:GFP29 (n= 6 ﬁsh, 33
fasicles) or her4.3:EGFP30 (n= 3 ﬁsh, 30 fasicles) to label
astroglia-like processes. This revealed that the majority of
fascicles that entered the lesion site were composed of
axons without detectable glial processes (49–53%). Some fascicles
contained both glial and axonal processes (20–21%) and
some pure glial fascicles were observed (27–30%; Fig. 1a and
Supplementary Movies 1 and 2; see Methods section for scor-
ing criteria). To conﬁrm these ﬁndings we used a range of
combinations of immunohistochemical and transgenic markers
for neuronal and glial processes in static images of live animals
and histological preparations at 1 dpl. This showed that 63–77%
of axon-containing fascicles (≙46–62% of all fascicles analysed)
were devoid of detectable glial processes (Fig. 1b). Nineteen to
26% contained both axonal and glial processes and 19–28% of
all analysed fascicles were only composed of glial processes.
Moreover, double-immunohistochemistry for anti-acetylated
Tubulin and anti-GFAP showed that at 1 dpl, only 36% of
animals had glial processes bridging the lesion site, in contrast to
57% of the ﬁsh with an axonal bridge. At 2 dpl, glial processes
had caught up (Fig. 1c). This suggests that axons cross the
lesion site more rapidly than glial processes. In summary,
these observations support that many axons rapidly extend into
the lesion site and cross it independently of detectable glial
processes.
To experimentally test a role of astroglia-like processes in
supporting axonal regeneration, we ablated the majority of glial
cells using gfap:Gal4ff;UAS:NTR-mCherry transgenic ﬁsh that
express the enzyme nitroreductase under regulatory sequences of
the gfap gene31. Adding the prodrug Metronidazole (MTZ) at 1
dpf, which is converted by nitroreductase into a cytotoxic
compound, almost completely eliminated transgene-expressing
glial cells by 3 dpf (Fig. 1d)31. A dramatic depletion of astroglia-
like processes in the lesion site was conﬁrmed by anti-GFAP
immunohistochemistry (Fig. 1e). Remarkably, this treatment
did not reduce the proportion of animals with axonal bridge
(anti-acetylated Tubulin+; Fig. 1e). This further supports that
glial processes do not have a major role in facilitating axonal
re-growth across a spinal lesion site. However, we cannot rule out
that glial processes that were not detected with our markers and
were spared by the ablation still supported axonal regeneration.
To explore possible substrates for the highly dynamic growth
cones other than glia, we determined regulation and protein
deposition for two major ECM components, collagen1a2 (col1a2)
and ﬁbronectin1a (fn1a). Both genes showed robust upregulation
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of expression in the lesion site (Fig. 1f). Using speciﬁc antibodies
we indeed observed an accumulation of Collagen I (Col I) and
Fibronectin proteins in the lesion matrix (Fig. 1g). The Col I and
Fibronectin immunoreactivity appeared diffuse, but also
formed ﬁbrous structures, often with a longitudinal orientation.
Double immunohistochemistry at 1 dpl revealed close apposition
of regenerating axonal fascicles (anti-acetylated Tubulin+)
with anti-Col I (11 of 13 fascicles associated with Col I
immunoreactivity; n= 7 ﬁsh) or anti-Fibronectin (15 of 22
fascicles associated with Fibronectin immunoreactivity; n= 6
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ﬁsh) immunoreactive ﬁbres in the lesion site (arrows in Fig. 1g,
Supplementary Movies 3 and 4). Hence, regenerating axons
navigate the non-neural lesion environment in close association
with ECM, suggesting that axon-ECM interactions might be
important for axonal re-growth.
Wnt signaling is activated after spinal cord lesion. To
determine a potential role of the Wnt/β-catenin pathway in
controlling the composition of the spinal lesion ECM, we ﬁrst
characterized the cells in which the pathway was active after
lesion. We used in situ hybridisation to detect transcripts of three
different transgenic reporter lines of Wnt/β-catenin-dependent
transcription, 6xTCF:dGFP, Top:dGFP, 7xTCF:mCherry22–24.
We also determined expression levels of direct Wnt/β-catenin
target genes axin2 and lef132, 33, which are commonly used as
read-outs of pathway activation and act as feedback inhibitor
(axin2) and transcriptional activator (lef1) in the pathway,
respectively (see Fig. 2a). All probes showed increased labelling in
the lesion site at 2 dpl (Fig. 2b; Supplementary Fig. 2a,b). Time
course analysis in the highly sensitive 6xTCF:dGFP Wnt
reporter line indicated incipient pathway activity in the lesion
site at 0.5 dpl (12 hpl; arrows in Supplementary Fig. 2c),
increased activity at 1 dpl, maximal activation at 2 dpl and
return to undetectable control levels by 5 dpl after dorsal
incision lesion or lateral stab lesion (Fig. 2b, Supplementary
Fig. 2d,e). This correlates well with the time course of axonal
regeneration. The 6xTCF:dGFP reporter also labelled a
few additional cells within the spinal cord at 1 and 2 dpl
(empty arrows in Fig. 2c). These cells have previously been
described as glial cells14.
6xTCF:dGFP reporter labelling was speciﬁc for Wnt/β-catenin
pathway activity in our experimental paradigm, as pharmacolo-
gical inhibition (IWR-1) or heat shock-induced ubiquitous
overexpression of the negative regulator axin1 in hs:Axin134
transgenic larvae strongly reduced the signal in the lesion
site (Supplementary Fig. 2f,g). Importantly, using anti-GFP
immunohistochemistry on whole mounts and sections conﬁrmed
the strong signal in the lesion site and only sparse labelling in the
adjacent spinal cord in 6xTCF:dGFP transgenic animals (Supple-
mentary Fig. 2h,i). Moreover, our in situ hybridization protocol
allowed us to detect gfp-expressing glial cells throughout the
spinal cord in whole mount preparations of 5 dpf her4.3:EGFP
transgenic ﬁsh (Supplementary Fig. 2j). This shows that lack of
labelling in neural tissue was not due to potential probe
penetration issues in whole mount preparations. Hence, after
spinal cord lesion, Wnt/β-catenin signaling is mainly increased in
the non-neural lesion site, which is a major, previously
undescribed, domain of Wnt/β-catenin pathway activity.
Wnt signaling is active mainly in ﬁbroblast-like cells. To
characterize the Wnt-responding cell types in the non-neural
lesion site environment, we utilized 6xTCF:dGFP transgenic
ﬁsh. GFP protein and mRNA was mainly detectable at the
lesion edge at 1 and 2 dpl (Fig. 2c; Supplementary Fig. 2h). Wnt-
responding cells did not co-label with markers of muscle
ﬁbres (MyHC/F5935, n> 10; Supplementary Fig. 3a,b) or immune
cells (L-Plastin36, n> 10; Supplementary Fig. 3c). In contrast,
31% of GFP-labeled cells (cell counts in immunolabeled sections
of individual animals, n= 10) were co-labeled with the basal
keratinocyte marker p6337 (arrowheads in Fig. 2d; Supplementary
Fig. 3d). The remaining two thirds of the Wnt-responsive cells
(6xTCF:dGFP+/p63−) were located subepidermally in the lesion
site and could thus be ﬁbroblasts. There is no deﬁnitive
ﬁbroblast marker. However, ﬁbroblasts are known to express the
ECM core components col1a2 and fn1a during dermal
stroma formation in developing zebraﬁsh38, 39. Indeed we found
that at 1 dpl and 2 dpl, Wnt-responding subepidermal cells
were positive for col1a2 and fn1a transcripts (arrows in Fig. 2e;
Supplementary Fig. 3e–g), which were both upregulated in the
lesion site (Fig. 1f). Interestingly, in the peripheral lesion area,
where the myotome was still intact, a population of 6xTCF:dGFP
+/p63− cells, continuous with the subepidermal cells in the lesion
site, were found sandwiched between basal keratinocytes (p63+)
and slow twitch muscle ﬁbres (MyHC/F59+) (insets in Supple-
mentary Fig. 3a,b). Additional 6xTCF:dGFP+/p63− cells were
found covering the spinal cord (arrows in Supplementary
Fig. 3h). These positions correspond to previously described
dermal and meningeal ﬁbroblast locations in the developing
zebraﬁsh and adult eel39, 40. Based on these observations, we
tentatively identify the vast majority of Wnt-responding cells as
ﬁbroblast-like. Importantly, we found ﬁbroblast-like Wnt-
responding cells (6xTCF:dGFP+/p63−) in close proximity to
regenerating axons (anti-acetylated Tubulin+) in the spinal lesion
site at 1 dpl (arrows in Fig. 2f). Hence, the majority of Wnt-
responding cells after a lesion are non-neural ﬁbroblast-like cells
that are part of the lesion environment through which axons
navigate.
Regeneration requires Wnt signaling in non-neural cells. To
functionally inhibit Wnt/β-catenin pathway activity selectively in
lesion site cells, we took advantage of the TetON system that
allows for Doxycycline (DOX)-inducible (Supplementary Fig. 4a),
cell type-speciﬁc pathway manipulation41. To interfere with Wnt/
β-catenin signaling, we used TetRE:Axin1-YFP transgenic ﬁsh, a
TetResponder line that has been shown to efﬁciently inhibit the
pathway when activated during zebraﬁsh development or adult
tail ﬁn regeneration25, 41. To speciﬁcally target cells that activate
Fig. 1 Regenerating axons navigate a non-neural lesion environment that is rich in ECM independently of astroglia-like processes. a Time-lapse video-
microscopy reveals that axonal growth cones (arrow, Xla.Tubb:DsRED) extend into the lesion site independently of astroglia-like processes (her4.3:EGFP,
empty arrow points out lack of glial labelling). Arrowhead indicates glial process extending into the lesion site. Single frames are shown. Abbreviations: ﬁn,
dorsal ﬁn fold; sc, spinal cord; nc, notochord. b Quantiﬁcation of fascicle composition at 1 dpl using different combinations of immunohistochemical and
transgenic markers for astroglia-like processes and axons indicates that the majority of fascicles are neuronal with no detectable glial component (46–62%
of all fascicles analyzed). In the example scans on the left, yellow arrows indicate mixed fascicles, containing neurites and glial processes; green arrows
indicate pure glial fascicles and red arrows indicate pure axonal fascicles. c Time course of re-growth of axons (anti-acetylated Tubulin+) and astroglia-like
processes (anti-GFAP+) after spinal cord transection. Quantiﬁcation of labelling continuity between rostral and caudal spinal cord stumps at 1 dpl and 2 dpl
suggests faster bridging of the lesion site by neuronal rather than glial processes. Arrow points to axonal bridge with very few glial processes in the lesion
site at 1 dpl at higher magniﬁcation (Fischer’s exact test: **P< 0.01; n.s. indicates not signiﬁcant). d Treatment of gfap:Gal4ff;UAS:NTR-mCherry transgenic
ﬁsh with the pro-drug Metronidozole (MTZ) almost completely ablates transgene-expressing glial cells by 3 dpf. e Treatment of gfap:Gal4ff;UAS:NTR-
mCherry transgenic ﬁsh with MTZ dramatically reduces anti-GFAP+astroglia-like processes (t-test: ***P< 0.001) but does not reduce the proportion of
larvae with axonal bridges at 2 dpl (Fischer’s exact test: n.s indicates not signiﬁcant). f fn1a and col1a2 expression is upregulated after lesion, shown
by in situ hybridization. g Regenerating axons (anti-acetylated Tubulin+; arrows) are closely associated with Collagen I and Fibronectin immunoreactivity
in a lesion site (confocal depth was limited to spinal cord). Also see Supplementary Movies 3 and 4. a–g Views are dorsal (a; rostral is left) or lateral
(b-g; dorsal is up, rostral is left). BF: brightﬁeld. Scale bars: 100 µm a,c–f and 50 µm b,g. Error bars indicate s.e.m
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the Wnt/β-catenin pathway in the lesion site, we generated
a TetActivator line using regulatory elements of the direct Wnt/β-
catenin target lef1 (lef1:TetA AmCyan; Supplementary Fig. 4b).
Indeed, this strategy showed injury-induced TetActivator
expression (amcyan mRNA) in Wnt-responding cells in the
lesion site in lef1:TetA AmCyan;6xTCF:dGFP double-transgenic
ﬁsh (Supplementary Fig. 4c). YFP ﬂuorescence was likewise
concentrated in the lesion site in lef1:TetA AmCyan;TetRE:Axin1-
YFP double-transgenic ﬁsh after DOX treatment (Fig. 3a,b). This
indicates successful selective targeting of Wnt-responding cells in
the lesion site. The inhibition was effective, as lesion site
expression of axin2, an established read-out for Wnt/β-catenin
pathway activity33 (Fig. 2a), was strongly reduced (Supplementary
Fig. 4d).
To determine whether functional spinal cord regeneration
was impaired in lef1:TetA AmCyan; TetRE:Axin1-YFP
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double-transgenic ﬁsh after DOX treatment, we scored ﬁsh
showing continuity of axonal labeling over the lesion site (anti-
acetylated Tubulin+) and quantiﬁed swim distance after touch at
2 dpl. The proportion of larvae with bridged lesion sites was
reduced by 48% (Fig. 3c). Moreover, larvae recovered to
swim only less than half the distance (42%) of unlesioned Wnt-
inhibited animals, whereas lesioned control larvae recovered
to swim the same distance as their unlesioned age-matched
controls (Fig. 3d).
Importantly, neuronal (Xla.Tubb:TetA AmCyan) and glial
(her4.3:TetA AmCyan25)-speciﬁc Axin1 induction did not
induce a phenotype, whereas ubiquitous expression (ubi:TetA
AmCyan25) recapitulated the axonal and behaviour phenotypes
of lesion site-speciﬁc manipulations (Fig. 3e–m; Supplementary
Fig. 4e). Of note, Axin1 was correctly targeted in all of these lines,
as indicated by YFP ﬂuorescence of the Axin1-YFP fusion
protein in neurons (Xla.Tubb:TetA AmCyan), glia (her4.3:TetA
AmCyan) or throughout the larvae (ubi:TetA AmCyan).
Moreover, axin1 induction in neural cells reached functional
levels. This is indicated in the neuronal-driven TetActivator
line (Xla.Tubb:TetA AmCyan), in which axin2 expression in
the lesion site remained unaffected but was strongly reduced in
a constitutively Wnt-responsive domain in the brain (Supple-
mentary Fig. 4f,g). Hence, Wnt/β-catenin pathway activity
in neurons or glia is not detectably involved in axonal
regeneration. To exclude non-speciﬁc effects of the TetON
system or Axin1-YFP induction, we also interfered systemically
with Wnt/β-catenin signaling using a pharmacological approach
(IWR-1) or via heat shock-induced ubiquitous overexpression of
the pathway antagonists axin1 or dkk1 in hs:Axin1 or hs:dkk142
transgenic ﬁsh, respectively. Using dkk1 overexpression as an
additional control was important, as it speciﬁcally antagonizes the
pathway at the receptor level, whereas axin1 overexpression
and IWR-1 promote degradation of the transcriptional co-
activator β-catenin (Fig. 2a; Supplementary Note 1). All of these
manipulations robustly reduced the proportion of larvae with
an axonal bridge (reduction by 51–72%) and functional recovery
(≤ 48% of the swim distance covered by unlesioned Wnt-
inhibited animals; Supplementary Fig. 5a–c). Inhibition of Wnt/
β-catenin signaling (IWR-1 treatment) starting at different time
points post-lesion showed that axon re-growth was still
maximally inhibited when the treatment was started at 0.5 dpl
(12 hpl), but the effect of IWR-1 was greatly diminished when the
treatment was started at 1 dpl and had no effect when it was
started at 1.5 dpl (Supplementary Fig. 5d). Hence, Wnt/β-catenin
pathway activity is required mainly between 0.5 dpl and 1 dpl
for axon regeneration, when axons actively grow across the
lesion site.
Two lines of evidence support that effects of Wnt/β-catenin
pathway inhibition on axon regeneration were not merely a
secondary consequence of potential defects in wound healing.
Firstly, a lateral stab lesion, which generates minimal tissue
disruption (Supplementary Fig. 2e), showed a similar reduction in
axonal regeneration and functional recovery after pharmacologi-
cal Wnt/β-catenin pathway inhibition, as was observed
after dorsal incision lesion (Supplementary Fig. 5e). Second,
wound re-epithelialization by basal keratinocytes, providing a
protective layer over the lesion site43, robustly occurred in
controls (30/30) and in larvae in which Wnt/β-catenin signaling
had been systemically inhibited using IWR-1 (30/30) (visualized
in krtt1c19e:EGFP transgenic ﬁsh44; arrow in Supplementary
Fig. 6; also see Fig. 4h). We conclude that Wnt/β-catenin
signaling in ﬁbroblast-like cells in the lesion site, but not in neural
cells, is necessary for functional axon regeneration.
Interestingly, systemic but not glial cell-speciﬁc Wnt-inhibition
also reduced the number of animals with glial bridges.
This suggests that glial crossing of the lesion site also depends
on Wnt/β-catenin signaling in a non-cell autonomous way
(Supplementary Fig. 7a,b).
Wnt signaling promotes Col XII deposition. We hypothesized
that Wnt/β-catenin signaling in lesion site ﬁbroblast-like cells
controls ECM deposition, as ﬁbroblasts are a major source
of ECM under physiological and pathological conditions. To
identify relevant Wnt/β-catenin-controlled ECM components, we
compared labelling intensities between control and IWR-1-
treated stab-lesioned larvae in an in situ hybridisation
screen for two ﬁbronectins and 44 collagen chain-encoding genes
at 1 dpl (Fig. 4a; Supplementary Fig. 8a). These genes were
chosen, because of roles of these ECM protein classes in axon
growth and regeneration17–20, 45. In DMSO-treated controls we
found expression of both ﬁbronectins and 10 collagens to
be locally upregulated in the lesion site compared to adjacent
unlesioned trunk tissue. Of these upregulated genes, only
expression of col6a2 and of the paralogs col12a1a and col12a1b
were noticeably reduced when Wnt/β-catenin signaling was
inhibited (IWR-1 treatment). We did not ﬁnd any increased
expression of ECM molecules after IWR-1 treatment. We focused
our further analysis on col12a1a and col12a1b, because both
paralogs code for the essential α-chain of Collagen XII (Col XII)
and are regulated by Wnt/β-catenin signaling. Since functional
Col XII molecules assemble as α-chain trimers, Col XII protein
expression likely also depends on Wnt/β-catenin signaling, as no
other paralogs were found in the genome that could substitute for
col12a1a and col12a1b46.
First we determined the time course of col12a1a/b expression
after a lesion. Parallel to the time course of Wnt/β-catenin
pathway activation, col12a1a/b transcripts were detectable in the
lesion site at 0.5 dpl (12 hpl). Further increased expression was
detected at 1 dpl, when axons started to regenerate. Expression
peaked at 2 dpl and had returned to baseline levels by 5 dpl
(Fig. 4b; Supplementary Fig. 8b).
To verify control of col12a1a/b expression by Wnt/β-catenin
signaling, we quantiﬁed ﬂuorescence in situ hybridisation signals
for col12a1a/b transcripts at 1 dpl after 24 h of IWR-1 treatment.
This conﬁrmed transcriptional downregulation of col12a1a and
Fig. 2 Wnt/β-catenin signaling is mainly active in ﬁbroblast-like cells after spinal cord lesion. a Cartoon showing relevant transcriptional read-outs of
Wnt/β-catenin pathway activity, feedback regulatory mechanisms and strategies to interfere with signaling at different levels of the pathway. Abbreviation:
β-cat., β-catenin. b Detection of gfp mRNA in the 6xTCF:dGFP transgenic reporter line shows transient activity of the Wnt/β-catenin pathway in the lesion
site during regeneration. c gfp expression is largely conﬁned to the lesion edge in 6xTCF:dGFP transgenic larvae (arrow). A few additional cells are labelled
within the presumptive spinal cord region (empty arrows). Abbreviations: nc, notochord; sc, spinal cord; ﬁn, dorsal ﬁn fold. d The 6xTCF:dGFP Wnt reporter
is mostly active in subepidermal p63− cells (arrows; ≥ 69% of all 6xTCF:dGFP+ cells at 1 dpl and 2 dpl), but also in p63+ basal keratinocytes (arrowheads) in
the lesion site. # indicates non-speciﬁc signal. e Consistent with a ﬁbroblast identity, subepidermal cells (below dashed line) co-express col1a2 (red) and gfp
mRNA (green) in a lesioned 6xTCF:dGFP transgenic animal (arrow). Dashed line indicates junction between basal epithelium and adjacent connective tissue.
f Fibroblast-like (6xTCF:dGFP+/p63−) cells are found in close proximity to regenerating axons (anti-acetylated Tubulin+) in the spinal lesion site at 1 dpl
(arrows). A single optical section is shown. a–f Views are lateral (b,c,f; dorsal is up, rostral is left) or transversal (d,e; dorsal is up) as indicated.
BF: brightﬁeld. Scale bars: whole mounts, 100 µm b,c and 25 µm f; sections: 100 µm. Error bars indicate s.e.m
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Fig. 3 Wnt/β-catenin signaling in non-neural cells is required for axon regeneration and functional recovery. a Schematic timeline of the experimental
design using the TetON system. b–d axin1 overexpression selectively in cells in the lesion site (b; lef1+) is sufﬁcient to interfere with axon regeneration
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col12a1b by 88% and 98% respectively (Fig. 4c). RT-PCR of lesion
site-enriched trunk tissue conﬁrmed that IWR-1 treatment
interfered with lesion-induced col12a1a and col12a1b upregula-
tion at 1 dpl, while col1a1a expression levels remained unaffected
by Wnt/β-catenin pathway inhibition (Supplementary Fig. 8c).
Consistent with our ﬁnding that Wnt/β-catenin pathway activity
is mainly required within the ﬁrst 24 h after a lesion for axonal
re-growth (Supplementary Fig. 5d), IWR-1 treatment for 24 h
between 1 dpl and 2 dpl had no effect on col12a1a/b expression.
(Supplementary Fig. 8d). This indicates that sustained Wnt/β-
catenin pathway activity was not needed for col12a1a/b
transcription.
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Activation of Wnt/β-catenin signaling through overexpression
of wnt8 for 24 h in hs:wnt8 transgenic ﬁsh47 enhanced expression
of both col12a1 genes at 1 dpl speciﬁcally in the lesion
site (Fig. 4d). Thus, gain- and loss-of-function experiments
for Wnt/β-catenin pathway activity support that zebraﬁsh
orthologs of the col12a1 gene are transcriptionally controlled
by Wnt/β-catenin signaling in a spinal lesion site in zebraﬁsh
larvae during the initial phase of axon regeneration.
To determine whether Wnt/β-catenin signaling regulates
col12a1a/b transcription in the lesion site likely directly or
indirectly, we compared the kinetics of down-regulation of
col12a1a/b expression after pathway inhibition with that of the
direct transcriptional target gene axin2 at 1 dpl. Short-term
inhibition of Wnt/β-catenin pathway activity through
axin1 overexpression in hs:Axin1 transgenic ﬁsh for 6 h was
sufﬁcient to abolish expression of axin2 while col12a1a and
col12a1b expression was not affected at that early time point
(Supplementary Fig. 8e). This indicates delayed and thus indirect
control of col12a1a/b transcription by Wnt/β-catenin
signaling. Taken together, these data support a scenario in which
Wnt/β-catenin signaling promotes axonal regeneration by
initiating col12a1a and col12a1b expression after a lesion.
To characterize the col12a1a and col12a1b-expressing cells in
the lesion site, we used multicolour ﬂuorescence in situ
hybridization. The majority of col12a1a and col12a1b-expressing
cells co-labeled with pdgfrb:GFP48 reporter transcripts, a marker
for pericytes and reactive ﬁbroblasts, at 1 dpl (Supplementary
Fig. 8f,g)49. Inhibition of Wnt/β-catenin signaling (IWR-1
treatment) did not overtly inhibit appearance of pdgfrb:GFP+
cells, indicating that Wnt/β-catenin signaling does not act on
potential migration of col12a1a/b-expressing cells into the lesion
site (Supplementary Fig. 8h). Some of the col12a1a and col12a1b-
expressing cells were also positive for 6xTCF:dGFP reporter
transcripts at 1 dpl (arrows in Fig. 4e). However, a substantial
proportion of col12a1a/b-expressing cells were not co-labelled
with 6xTCF:dGFP reporter transcripts, indicating that
expression of col12a1a and col12a1b was not exclusive to acutely
Wnt-responding cells. Hence, Wnt/β-catenin pathway activity
could have already ceased in the majority of col12a1a
and col12a1b-expressing cells at the time point of analysis or
Wnt-responding cells could induce additional non-neural cells in
the lesion site to express these genes.
We next assessed whether Col XII protein deposition
was altered by inhibition of Wnt/β-catenin signaling. We found
increased immunoreactivity of Col XII in the lesion site at 1 dpl
and 2 dpl in control lesioned larvae compared to adjacent
unlesioned trunk tissue or unlesioned control animals (arrows in
Figs. 4f,g and Supplementary Fig. 9a). Inhibition of Wnt/β-
catenin signaling by IWR-1 treatment or after heat shock-induced
overexpression of dkk1 in hs:dkk1 transgenic ﬁsh, led to lower Col
XII immunoreactivity in lesioned larvae than in DMSO-treated
controls (Fig. 4h, Supplementary Fig. 9b). Hence, strongly
reduced levels of Col XII matrix are laid down in the lesion site
under conditions of Wnt/β-catenin pathway inhibition.
To analyse the relationship of regenerating axons and Col XII,
we used double-immunolabelling of axons (anti-acetylated
Tubulin+) and Col XII. This showed little to no Col XII
deposition in the lesion site at 0.5 dpl (12 hpl) and no axons that
had entered the lesion site at this time point (asterisk in
Supplementary Fig. 9c). In contrast, at 1 dpl we detected
prominent anti-Col XII immunoreactivity (Supplementary
Fig. 9c) and regenerating axons were present in the lesion site
in close proximity to Col XII immunoreactivity (arrowheads in
Fig. 4i, Supplementary Movie 5). The trajectory of axonal fascicles
frequently appeared to follow longitudinal ﬁbres of Col XII
immunoreactive ECM material (arrowheads in Fig. 4j). We found
31 axonal fascicles of 45 in close apposition with Col XII positive
ﬁbres at 1 dpl (n= 14 ﬁsh). Thus, Col XII deposition correlates
well with axonal re-growth in larvae.
In adult zebraﬁsh, lesion site-speciﬁc expression of col12a1a as
well as Col XII deposition was also observed at 7 dpl and 14 dpl
(Supplementary Fig. 10a,b). At 14 dpl, anti-acetylated Tubulin+
spinal axons entered the lesion site in close contact with Col XII
immunoreactivity, resembling the larval pattern (Supplementary
Fig. 10b). Thus, after spinal cord injury, deposition of Col XII
matrix in the lesion site is conserved across developmental
stages in zebraﬁsh. Taken together, this supports a scenario in
which Wnt/β-catenin signaling is necessary for the correct
expression and deposition of Col XII in the spinal lesion site,
which in turn promotes axon regeneration.
Col XII promotes functional spinal cord regeneration. To
determine whether Col XII deposition is required for functional
axonal regeneration, we co-injected Vivo-Morpholinos (MO),
which act as cell-permeable translation blocking anti-sense
molecules for col12a1a and col12a1b, into the circulation for
efﬁcient distribution in 3 dpf larvae (Supplementary Fig. 11a50).
This approach effectively reduced Col XII immunoreactivity
in the lesion site compared to control MO-injected larvae
(Fig. 5a,b). In contrast, immunoreactivity for Fibronectin
and Collagen I was unaffected (Supplementary Fig. 11b),
indicating speciﬁcity of the manipulation for col12a1a/b
expression.
The proportion of larvae with an axonal bridge (determined in
Xla.Tubb:DsRED transgenic animals) was reduced by 43% in
col12a1a/b morphants compared to control MO-injected larvae
at 2 dpl (Fig. 5c). In lesioned col12a1a/b morphants swimming
Fig. 4 Wnt/β-catenin signaling controls col12a1a/b transcription and Col XII deposition in a spinal lesion site. a Wnt/β-catenin pathway inhibition (IWR-1)
results in lower expression of select collagen genes (red box) in the lesion site at 1 dpl, determined by in situ hybridization. b col12a1a and col12a1b
expression is transiently upregulated in the lesion site during regeneration. c Inhibition of Wnt/β-catenin signaling (IWR-1) interferes with col12a1a/b
expression in the lesion site (t-test: ***P< 0.001). d wnt8 overexpression upregulates col12a1a/b expression in the lesion site in hs:wnt8 transgenic ﬁsh
(t-test: *P< 0.05, **P< 0.01). Signal was underdeveloped to optimize detection of differences in signal strength. e A subpopulation of col12a1a or col12a1b-
expressing cells (red) in the lesion site co-labels with transcripts of the 6xTCF:dGFP Wnt reporter (green, arrows). f,g Anti-Col XII immunoreactivity is
increased in the lesion site (arrows) compared to adjacent unlesioned trunk tissue at 1 dpl. Shown is a confocal image of a whole mount (f, confocal depth
was limited to spinal cord) and a transversal section though the lesion site g,h Inhibition of Wnt/β-catenin signaling (IWR-1) interferes with Col XII
deposition in the lesion site (t-test: **P< 0.01). Note continuity of tissue in IWR-1-treated animals as shown by re-epithelialization of the lesion site by
basal keratinocytes in krtt1c19e:EGFP transgenic ﬁsh. i,j Double immunolabelling of axons (anti-acetylated Tubulin+) and Col XII shows Col XII matrix
deposition in the lesion site through which regenerating axons grow i. Shown is a maximum intensity projection in i with inset higher magniﬁcation;
the confocal depth was limited to spinal cord. Arrowheads point to regenerating axonal fascicle in close apposition to Col XII immunoreactivity (also
see Supplementary Movie 5). Note, that the trajectory of axonal fascicles appear to follow longitudinal ﬁbres of Col XII immunoreactive ECM
material in the lesion site (j, arrowheads). a–j Views are lateral (a–d,f,h–j; dorsal is up, rostral is left) or transversal (e,g; dorsal is up). BF: brightﬁeld.
Scale bars: 100 µm a–d,f,h, 50 µm e,g,i, 25 µm j. Error bars indicate s.e.m
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distance was reduced by 58% compared to unlesioned col12a1a/b
MO-injected larvae (Fig. 5d). Importantly, Vivo-Morpholino
treatment was not toxic, since lesioned control MO-injected
larvae recovered to the same swimming capacity as unlesioned
age-matched control MO-injected larvae at 2 dpl, and col12a1a/b
MO treatment did not impair swimming in unlesioned animals.
Impaired functional regeneration after MO knockdown
supports that Col XII is part of the axon-growth promoting
ECM in the lesion site.
To independently conﬁrm the function of col12a1a/b, we
used transient CRISPR/Cas9-mediated gene editing. Injection
of small guide-RNA (gRNA) and cas9 mRNA into the
zygote efﬁciently generates biallelic mutations of targeted genes
in a very high proportion of cells, leading to loss-of-function
phenotypes51. Indeed, targeting of col12a1a and coll12a1b
efﬁciently disrupted both genes in CRISPR-injected embryos, as
shown by loss of targeted endonuclease restriction sites (Fig. 6a,
b). Quantitative RT-PCR indicated reduced abundance of
transcripts at 1 dpf, likely caused by non-sense mediated RNA
decay in CRISPR-manipulated larvae (hereafter referred to as
Crispants; Fig. 6c). Similarly, after a spinal lesion in Crispants the
abundance of both col12a1a and col12a1b mRNAs in the lesion
site was also reduced, as determined by quantiﬁcation of
ﬂuorescence in situ hybridisation signals (Fig. 6d). Targeting of
only col12a1a or col12a1b did not affect axonal regeneration,
possibly due to compensation of the non-targeted paralog
(Supplementary Fig. 12a). In contrast, in Crispants in which
both col12a1 genes were targeted, the proportion of larvae with
axonal continuity (anti-acetylated Tubulin+) between spinal cord
ends was reduced by 31% compared to controls (Fig. 6e). Single
larvae analysis showed that lack of axonal bridging in col12a1a
and col12a1b-targeted animals (analysed in Xla.Tubb:DsRED
transgenic ﬁsh) correlated with high gene editing efﬁciency of
both col12a1 paralogs, supporting speciﬁcity of the CRISPR/Cas9
manipulation (Supplementary Fig. 12b). Hence, both MO
knockdown and CRISPR manipulation indicate an important
contribution of Col XII to functional spinal cord regeneration in
zebraﬁsh.
To determine the relevance of Col XII as a downstream effector
of Wnt/β-catenin signaling, we asked whether experimentally
increasing expression of col12a1a was sufﬁcient to rescue the
regeneration phenotype induced by inhibition of the Wnt/β-
catenin pathway. To this end, we created zebraﬁsh that are
transgenic for heat shock-inducible expression of full-length
col12a1a (hs:col12a1a-p2a-Cerulean, short hs:col12a1a; Supple-
mentary Fig. 13a). Activation of the transgene in unlesioned
animals increased anti-Col XII immunoreactivity in develop-
mental Col XII domains but also in ectopic sites, including the
spinal cord (arrow in Supplementary Fig. 13b). To increase Col
XII deposition in the lesion site, we applied repetitive heat shocks
to hs:col12a1a transgenic animals until immediately before the
lesion (3 dpf). This treatment increased detectability of transgene
mRNA for at least 24 h after the last heat shock (Fig. 7a) and was
sufﬁcient to increase Col XII immunoreactivity in the lesion site
of larvae in which the Wnt/β-catenin pathway was inhibited
(IWR-1 treatment; analyzed at 2 dpl; arrow in Fig. 7b). We found
that under these experimental conditions, col12a1a overexpres-
sion more than doubled the proportion of IWR-1-treated larvae
with axonal bridge to 77% of all lesioned larvae, compared to 32%
in only IWR-1-treated lesioned larvae (determined in Xla.Tubb:
DsRED transgenic animals; Fig. 7c). This represents a rescue of
the axonal bridging phenotype to near wild type levels (compare
Supplementary Fig. 1b). col12a1a overexpression also improved
functional recovery in IWR-1-treated larvae (+ 55% of the swim
distance covered by Wnt/β-catenin pathway-inhibited lesioned
animals; Fig. 7d). This identiﬁes Col XII as a major downstream
effector of Wnt/β-catenin signaling in the regenerating zebraﬁsh
spinal cord.
We next asked whether col12a1a overexpression is sufﬁcient
to augment axon regeneration. To this end, we assessed
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Fig. 5 Knockdown of col12a1a/b inhibits functional axon regeneration. a Cartoon showing strategy used for systemic delivery of Vivo-Morpholino (MO),
which acts as cell-permeable translation blocking anti-sense molecules. MOs against col12a1a and col12a1b were co-injected into the cardiac ventricle at
3 dpf, 4 h before lesion. b col12a1a/b MO injection strongly reduces Col XII immunoreactivity in the lesion site compared to control MO injected animals.
(t-test: ***P< 0.001). c col12a1a/b MO injection inhibits axon regeneration after lesion (Fischer’s exact test: ***P< 0.001). d col12a1a/b MO injection
interferes with functional recovery after lesion (two-way ANOVA: F1,116= 5.534, p< 0.05; t-test: ***P< 0.001). a–d Lateral views are shown (dorsal is up,
rostral is left). BF: brightﬁeld. n.s.: not signiﬁcant. Scale bars: 200 µm c and 100 µm (b,c). Error bars indicate s.e.m
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axonal bridging in hs:col12a1a transgenic animals and their
wild type control siblings at 18 hpl (Fig. 7e). At this early
time point, 41% of lesioned control larvae showed axonal
continuity (anti-acetylated Tubulin+) between spinal cord ends.
Remarkably, col12a1a overexpression increased the proportion of
larvae with axonal bridge to 63%. Thus, Col XII is sufﬁcient
to enhance axon regeneration after a spinal lesion in
zebraﬁsh. Taken together, these ﬁndings determine Col XII as
major pro-regenerative, Wnt/β-catenin-controlled ECM factor in
the spinal lesion site.
Discussion
Here, we demonstrate an important role for Wnt/β-catenin
signaling in controlling the composition of the spinal lesion ECM,
which is essential for functional axon regeneration in
zebraﬁsh. Our data support a model (Fig. 8) in which spinal cord
transection triggers upregulation of Wnt/β-catenin signaling in
non-neural cells. The vast majority of these are ﬁbroblast-like
cells accumulating in the lesion site. Wnt/β-catenin signaling
regulates col12a1 transcription and deposition of Col XII by
ﬁbroblast-like cells in the spinal lesion ECM. The presence of Col
XII in the ECM promotes axon growth across the lesion site and
functional recovery.
How does Col XII support axonal regeneration? Col XII is
abundant in the spinal lesion site in species of high regenerative
capacity, such as in larval and adult zebraﬁsh (this report) and
salamanders6. Col XII is a member of the FACITs family of
collagens, which do not form supramolecular aggregates but
are associated with Collagen ﬁbrils46, 52. Previously, Col XII
was found to interact with Col I ﬁbrils52. However, we ﬁnd that
Col I immunoreactivity remained grossly unchanged after
interfering with col12a1a/b translation. Col XII also interacts
with Col VI in forming matrix bridges between developing
osteoblasts53. Interestingly, we ﬁnd in our expression screen
that col6a2, coding for a Col VI α-chain, is co-regulated
with col12a1a/b by Wnt/β-catenin signaling, which may be
related to functional interactions of the proteins. In
addition, Col XII binds a variety of other matrix proteins, such as
Tenascin-X, Decorin, and Fibromodulin54, 55. Hence, Col XII
could promote growth of axons indirectly by organising the
lesion site ECM. Another possibility is that Col XII could
directly interact with axons via speciﬁc receptors. This is
supported by our observation that overexpression of col12a1a
alone is sufﬁcient to enhance axonal regeneration.
While speciﬁc axonal receptors for Col XII have not been
identiﬁed, potential direct Col XII-axon interactions could
be mediated by its integrin-binding site, the NC1 domain,
as reported for Col IV46, 56, 57. Future studies will need to
clarify the precise mechanism by which Col XII promotes axonal
re-growth.
While our results identify Col XII as critical factor for axon
regeneration, several additional ECM molecules likely contribute
to establishing the growth promoting lesion site environment
found in zebraﬁsh. For example, Tenascin-C has been shown
to be important for spinal cord regeneration in zebraﬁsh, but
possible interactions with Col XII are not known5. Furthermore,
Col I and Fibronectin, which we ﬁnd to be abundantly present in
the lesion site, are also known ECM components that promote
axons growth45, 58, 59.
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How does Wnt/β-catenin signaling act on col12a1a/b
expression? Wnt-responding cells co-express col12a1a/b. Hence,
Wnt/β-catenin pathway activity likely acts in the same cells to
increase expression of col12a1a/b after a lesion. Regulation of
Collagens in ﬁbroblasts by Wnt/β-catenin signaling has also
been observed in dermal ﬁbroblasts or myoﬁbroblasts in the
context of ﬁbrosis8–10, 60. However, a sizable population of
ﬁbroblast-like cells showed Wnt-dependent col12a1a/b
upregulation without having detectable Wnt/β-catenin pathway
activity. Our results show that the effect of Wnt/β-catenin
pathway inhibition on col12a1a/b expression is delayed and
therefore likely indirect and that Wnt/β-catenin signaling does
not need to be sustained for col12a1a/b expression and successful
regeneration. These observations are consistent with the
possibility that Wnt/β-catenin signaling is only transiently active
in col12a1a/b-expressing cells. Alternatively, secondary signals
from Wnt-responding cells could instruct transcriptional
regulation of col12a1a/b in non-Wnt-responsive cells.
Are astroglia-like cell bridges a necessary substrate for axonal
regeneration across a spinal lesion site? Regenerating axons could
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directly interact with the lesion site ECM or simply follow glial
processes that bridge the lesion site. In histological preparations
this is difﬁcult to assess, as axons and glial processes tend to
fasciculate27. Indeed, at 2 dpl almost all tissue bridges
were composed of neuronal and glial processes. However,
simultaneous time-lapse video microscopy imaging of axonal
and glial processes indicated that the majority of axons highly
dynamically enter and cross the lesion site independently of glial
processes. Moreover, our data show that re-establishment of
axonal continuity of the transected spinal cord precedes that of
glial continuity, similar to observations in the lesioned spinal cord
of the adult eel61. Finally, in contrast to reducing the amount of
Col XII protein in the lesion site, massive depletion of glial
processes did not reduce the proportion of animals that showed
axonal continuity after regeneration. While these observations
support the relative importance of the ECM compared to that of
glial substrates for axonal regeneration, we cannot exclude that
ﬁne glial processes that escaped detection and ablation still served
as a substrate for axon re-growth. Moreover, glial processes are
likely to support regeneration by physically aligning with regen-
erating fascicles27 and producing essential growth-factors28,
which may be more important in a larger lesion site of adult
zebraﬁsh.
Is larval regeneration comparable to adult spinal cord
regeneration? In both larvae and adult zebraﬁsh, functional
regeneration after complete spinal cord transection depends
on axons successfully crossing a non-neural lesion site (this report
and refs. 11, 13, 28) and forming connections11, 12. Both show
lesion-speciﬁc upregulation of col12a1a and axons regenerate in
close proximity to Col XII in larval and adult zebraﬁsh (this
report). At least some axons grow independently of glia at both
developmental stages (this report and ref. 27) and, crucially both
larval and adult regeneration depend on Wnt/β-catenin signaling
(this report and refs. 14, 15). This suggests that key aspects of
regeneration are conserved across developmental stages. How-
ever, regeneration times in adults are much longer than in lar-
vae62, such that timing of signaling processes may differ in adults.
In conclusion, Col XII deposition, controlled by Wnt-
responsive ﬁbroblasts, promotes spinal cord regeneration in
zebraﬁsh. Interestingly, transplanting Wnt3a-secreting ﬁbroblasts
into a spinal lesion site in rats enhances functional recovery63.
Thus, elucidating the molecular cues that promote axon
regeneration in zebraﬁsh could provide strategies in mammals
to modulate the composition of the lesion site to tip the balance
towards a growth-conducive ECM environment.
Methods
Animals. All ﬁsh were kept and bred in our laboratory ﬁsh facility according to
standard procedures64, and all experiments have been approved by the British
Home Ofﬁce (project license no.: 70/8805). Details of the transgenic zebraﬁsh
lines used can be found in Supplementary Note 1. We used the WIK wild type
strain of zebraﬁsh and the following transgenic zebraﬁsh lines: 6xTCF/Lef-
miniP:2dGFP (6xTCF:dGFP24); 7xTCF-Xla.Siam:nlsmCherry1a5 (7xTCF:
mCherry23); gfap:Gal4ffs995;UAS-E1b:Eco.NfsB-mCherryc264 (gfap:Gal4ffs995;UAS:
NTR-mCherry31);gfap:GFPmi200129, her4.3:EGFPy83 (formerly known as her4.1:
EGFP30); her4.3:irtTAM2(3F)-p2a-AmCyanulm6 (her4.3:TetA AmCyan25); her4.1:
Tet-GBD-p2A-mCherrytud6 (her4.3:mCherry41); hsp70l:dkk1-GFPw32 (hs:dkk142);
hsp70l:Mmu.Axin1-YFPw35 (hs:Axin134); hspl70l:wnt8a-GFPw34(hs:wnt847);
krtt1c19e:EGFPsq1744, pdgfrb:Gal4ffncv24;UAS:GFP (pdgfrb:GFP48) TetRE:Mmu.
Axin1-YFPtud1 (TetRE:Axin1-YFP41); Top:dGFPw2522; ubiquitin:irtTAM2(3F)-p2a-
AmCyanulm2(ubi:TetA AmCyan25);Xla.Tubb:DsREDzf14826. The lef1:irtTAM2(3F)-
p2a-AmCyanulm11 (lef1:TetA AmCyan), Xla.Tubb:irtTAM2(3F)-p2a-AmCyanue103
(Xla.Tubb:TetA AmCyan) and hsp70l:col12a1a-p2a-Cerulenue104 (hsp70l:col12a1a)
transgenic zebraﬁsh lines were established by Tol2-mediated transgenesis65 using
the DNA constructs described below.
DNA constructs. The lef1:irtTAM2(3F)-p2A-AmCyan construct was generated by
replacing the translation start codon of lef1 in the BAC clone CH73-164H6 with
the previously described irtTAM2(3F)-p2A-AmCyan TetActivator cassette41, 66
using standard BAC recombination techniques67. Additionally, Tol2 inverted
repeats were introduced into the BAC backbone. The ﬁnal BAC was puriﬁed using
the HiPure Midiprep kit (Invitrogen). The Xla.Tubb:irTAM2(3F)-p2A-AmCyan
construct was generated by cloning the previously described sequence of the
Xenopus laevis neural-speciﬁc beta tubulin regulatory element (Xla.Tubb2b)
upstream of the published doxycycline (DOX)-inducible transcriptional
activator [irtTAM2(3F)] tagged with p2a and AmCyan26, 41, 66. For generation of
the hsp70l:col12a1a-p2a-Cerulean construct, 3 overlapping fragments spanning
the full-length col12a1a CDS were ampliﬁed from 1 dpl cDNA (primer
sequences are given in Supplementary Table 1) and fused via internal restric-
tion sites (BsiWI, BsrGI). The complete col12a1a CDS was then subcloned into the
hsp70l:irtTAM-p2a-Cerulean construct41 thereby replacing the irtTAM TetActi-
vator CDS.
Reverse transcriptase PCR and quantitative RT-PCR. To assess the effect
of IWR-1 treatment on lesion-induced gene expression total RNA from lesion site-
enriched trunk tissue was extracted using Trizol (Invitrogen). Twenty larvae
were pooled for each experimental condition. To assess the effect of col12a1a/b
gRNA/cas9 mRNA microinjection on developmental col12a1a/b mRNA levels
total RNA from ten 24 hpf embryos was extracted using Trizol. Reverse
transcription of 500 ng RNA was performed with the SuperScript III kit
(Invitrogen) using a combination of oligo(dT) and random hexamer primer.
Standard RT-PCR (58 °C, 30 cycles) was performed using 10 mM of each
dNTP and 10 μM of each primer. qRT-PCR was performed at 58 °C using
Roche Light Cycler 96 and relative mRNA levels determined using Roche Light
Cycler 96 SW1.1 software. Samples were run in triplicate and expression levels
were normalized to β-actin control. Primer were designed to span an exon–exon
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(pdgfrb+)
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col12a1
Col XII deposition
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Fig. 8 Model for Wnt/β-catenin function during axonal regeneration in the
zebraﬁsh spinal cord. Spinal cord (sc) lesion triggers Wnt/β-catenin
pathway activation in ﬁbroblast-like cells. Wnt/β-catenin signaling controls
col12a1a/b transcription and deposition of Col XII in the lesion site ECM,
through which axons regenerate to facilitate functional recovery.
Interference with Wnt/β-catenin signaling in ﬁbroblast-like cells or Col XII
deposition prevents axon regeneration and functional recovery
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junction using Primer-BLAST software. Primer sequences are given in
Supplementary Table 2.
Spinal cord lesions and behavioral recovery. Zebraﬁsh larvae (3 dpf) were
anesthetized in PBS containing 0.02% aminobenzoic acid ethyl methyl ester
(MS222; Sigma-Aldrich). For dorsal incision lesions, larvae were transferred to a lid
of a plastic Petri dish. Following aspiration of excess water, which placed the larvae
in a lateral position, the tip of a sharp 30 G syringe needle was used to inﬂict a
lesion in the dorsal trunk at the level of the anal pore. Survival of larvae was
typically > 95%. Larvae that had undergone extensive damage to the notochord
showed the formation of a notochord-derived bulgy tissue structure (~ 10%). Those
larvae were excluded from further analysis. For less invasive stab lesions, larvae
were transferred to an agarose-coated Petri dish and larvae were placed in a lateral
position through removal of excess water. The tip of a sharp 30 G syringe needle
was pushed through the spinal cord at the level of the anal pore immediately dorsal
to the notochord. Kinetics of anatomical/functional spinal cord regeneration were
comparable in larvae that underwent dorsal incision lesion or stab lesion. After
surgery, larvae were returned to E3 medium for recovery and kept at 28.5 °C.
Wherever possible, Xla.Tubb:DsRED transgenic larvae were used for experiments
to visually verify completeness of spinal cord transection after lesion. Analysis of
behavioral recovery was performed as described previously13. Behavioral data are
shown as distance travelled within 15 s after touch, averaged for triplicate measures
per larvae. Adult spinal cord lesions have been described previously62. Brieﬂy, ﬁsh
(≥ 3 month post-fertilization) were anesthetized by immersion in 0.02% MS222 in
PBS for 5 min. A longitudinal incision was made at the side of the ﬁsh to expose the
vertebral column. The spinal cord was completely transected under visual control,
3.5 mm caudal to the brainstem-spinal cord junction.
Drug treatments and heat-shock treatments. Heat shocks and drug treatments
were performed according to the schematic timelines shown with each experiment.
For heat shocks, larvae were kept in 50 ml conical centrifuge tubes ﬁlled with 40 ml
E3 embryo medium, which ﬂoated in a programmable thermostat-controlled water
bath (Lauda, Germany). Heat shocks of transgenic animals and non-transgenic
sibling controls were performed for 1 h at 38 °C after which larvae were returned to
28.5 °C. For drug treatments, up to 10 larvae were incubated in 7 ml of E3 embryo
medium, containing the drug. Larvae were kept in the dark at 28.5 °C and water
was exchanged daily. The Axin1 stabilizer IWR-1 (Sigma-Aldrich) was dissolved in
DMSO (6 mM stock) and used at a ﬁnal concentration of 15 µM. Doxycycline
(DOX; Sigma-Aldrich) was dissolved in 50% EtOH (50 mg/ml stock) and used at
a ﬁnal concentration of 40 µg/ml. For targeted cell ablation, the pro-drug
Metranidozole (MTZ; Sigma-Adrich) was dissolved in DMSO (200 mM) and used
at a ﬁnal concentration of 2 mM.
Morpholino injection. Knockdown of col12a1a/b was performed by injecting
Vivo-Morpholinos (MO) to col12a1a/b, which act as cell-permeable
translation blocking anti-sense molecules, into the circulation for efﬁcient
distribution in 3 dpf larvae (Supplementary Fig. 11a50). Two translation blocking
Vivo-Morpholinos, antisense to the transcriptional start site of col12a1a
(ENSDART00000154728) and col12a1b (ENSDART00000025926), were
designed (Gene Tools, Philomath, OR, USA): col12a1a MO 5′-CGGCCAAAGA-
CAACCTGATCTTCAT-3′; col12a1b MO 5′-TGCCAAATGCCTGACCGA-
CATCTTC-3′. 100% homology of MO sequences to target sites were conﬁrmed
by sequencing. Approximately a total of 27 nl injection mix (9 repetitive injections
3 nl each), containing Cascade Blue Dextran (MW: 3000; Molecular Probes) and
0.25 mM of each Morpholino, was injected directly into the ventricle of 3 dpf larvae
as described previously50. Larvae that showed strong and ubiquitous
ﬂuorescence at 2–3 h post-injection were subsequently lesioned. As control a
standard Vivo-Morpholino from Gene Tools was used.
CRISPR-mediated genome editing. CRISPR col12a1a and col12a1b gRNA were
designed using a combination of different webtools: ZiFit (http://ziﬁt.partners.org/
ZiFiT), CRISPR Design (http://crispr.mit.edu), and Mojo Hand (http://talendesign.
org). gRNA expression vectors were built by ligation of annealed oligonucleotides
into pT7-gRNA expression vector (Addgene #46759) as described previously51.
Capped sense nls-zCas9-nls RNA was synthesized using mMESSAGE mMACHINE
T3 kit (Ambion) and pT3TS-nCas9n (Addgene # 46757) as template51. RNA was
puriﬁed using RNAeasy Mini Kit (Qiagen). gRNA was in vitro transcribed from
gRNA expression vectors using mMESSAGE mMACHINE T7 kit and puriﬁed
using mirVana miRNA isolation kit (Ambion). All synthesized RNAs were assessed
for size and quality by gel electrophoresis. A mix of 75 pg gRNA and 150 pg nls-
zCas9-nls RNA was microinjected into one-cell-stage embryos to determine efﬁ-
ciency of individual gRNAs to introduce mutations in the target site in pools of 24
hpf embryos using restriction fragment length polymorphisms (RFLP) analysis. For
subsequent experiments we used a combination (75 pg each) of col12a1a gRNA#1
(target sequence 5′-GGCTGTGGTTCAGTACAGCT-3′; targeting exon 6) and
col12a1b gRNA#1 (target sequence 5′- GGTCAGGCATTTGGCAGCGG-3′;
targeting exon 2) and 150 pg nls-zCas9-nls RNA for microinjection. A previously
described gRNA targeting GFP (target sequence: 5′GGCGAGGGCGATGC-
CACCTA-3) served as control68. Efﬁcient mutagenesis of target loci was conﬁrmed
after each injection by RFLP analysis as follows. For col12a1a gRNA#1, a 308 bp
fragment was ampliﬁed using primers 5′- TGGAGTGTGGGAAGAGAAAACTT-
3′ and 5′- CTAATGAGAATTTGTCGGCAGCG-3′ and digested with AluI. For
col12a1b gRNA#1, a 400 bp fragment was ampliﬁed using primers 5′-TGGAG-
CATGTATTTTCCCCTTGA-3′ and 5′-GCTCCAGTCCTTTTGTTCATTCC-3′
and digested with AciI.
Live imaging of zebraﬁsh larvae and time-lapse imaging. For live confocal
imaging, zebraﬁsh larvae were anesthetized in PBS containing 0.02% MS222 and
mounted in the appropriate orientation in 1%low melting point agarose (Ultra-
PureTM, Invitrogen). During imaging the larvae were covered with 0.01% MS222-
containing ﬁsh water to keep preparations from drying out. For time-lapse ima-
ging, agarose covering the lesion site was gently removed after gelation. Time-lapse
imaging was performed for 19 h starting at 6 hpl. After initial visual inspection,
acquired time-lapse images were denoised to improve image quality (enhance
detail). Background noise, caused by the low signal to noise ratio, was removed
from acquired time-lapse images using the ImageJ plugin CANDLE-J algorithm,
which allows to remove the noise compartment while preserving the structural
information with high ﬁdelity69. We veriﬁed that this procedure did not remove
signals from processes of low ﬂuorescence intensity by comparing raw movies
with CANDLE-J-processed movies, which showed that that edges of features
remained conserved after denoising.
Quantiﬁcations and statistics. Re-established axonal or glial connections
(bridges) were scored in static preparations (ﬁxed immunolabelled samples, live
transgenic animals) or in still images of time-lapse movies at time points of interest.
Larvae were directly visually evaluated using a compound ﬂuorescence microscope
(Zeiss Imager.Z1), or after confocal imaging (Zeiss LSM 710, 880). A larva was
scored as having a bridged lesion site when continuity of the neuronal or glial
labeling between the rostral and caudal part of the spinal cord was observed.
Continuity of labeling was deﬁned as at least one fascicle being continuous between
rostral and caudal spinal cord ends irrespective of the fascicle thickness. Larvae in
which the lesion site was obscured by melanocytes were excluded from analysis.
For all quantiﬁcations, the observer was blinded to the experimental treatments.
Scores of key experiments were validated by a second independent observer.
Quantiﬁcation of axonal and glial fascicle composition in static preparations at
1 dpl was performed after confocal imaging (Zeiss LSM 880) of immunolabeled or
live animals. Fascicles were identiﬁed as ﬂuorescent protrusions from the severed
spinal cord that projected into the injury site for at least 20 µm or had crossed it
completely. This was done by inspecting single optical sections and 3D renderings
of the lesion site. If more than half of the length of a fascicle contained ﬂuorescence
for both glial and neuronal markers it was scored as “mixed”, otherwise it was
scored as purely “axonal” or “glial” depending on the markers used. The threshold
of half the length was used to exclude situations in which one type of process
followed the other long after that one was established.
For quantiﬁcation of axonal and glial fascicle composition in time-lapse movies
we included only fascicles that grew during the observation period.
Fascicles were classiﬁed as purely “axonal” or “glial” when the distal part of a
given fascicle was labelled by the respective marker throughout the entire
observation period. In “mixed” fascicles, both markers were present in the distal
portion of the fascicle.
Fascicles were considered to be in close apposition with ECM in histological
preparations when > 50% of an axonal fascicle that had entered or crossed the
lesion site was aligned with ECM immunoreactivity. This was assessed in single
optical sections and 3D renderings.
Quantiﬁcation of immunohistochemistry or ﬂuorescent in situ hybridization
signal in the lesion site was performed on captured images of whole mount samples
using ImageJ software as described in subsection “Image analysis”. Samples were
imaged using a compound ﬂuorescence microscope (Zeiss Imager.Z1) or confocal
microscope (Zeiss LSM 710, 880). Measurements were performed in a blinded
fashion.
Quantiﬁcation of GFP+/p63+ and GFP+/p63− cells in 1 dpl and 2 dpl 6xTCF:
dGFP transgenic larvae was performed on immunolabeled sections of individual
animals (n= 10).
For non-quantitative data, the number of specimens that showed a given
phenotype and the total number of specimens analyzed is given as a ratio in each
ﬁgure. Phenotypes were scored in a blinded fashion.
All experiments were performed at least three times. Animals were randomly
assigned to different experimental groups but no formal method of randomisation
was used. Power analysis of pilot experiments informed minimum samples size.
All quantitative data were tested for normality and analyzed with parametric and
non-parametric tests as appropriate. An F-test was used to check for equal
variances. We used one-way ANOVA followed by Dunn’s multiple comparison
test, two-way ANOVA, followed by Student’s t-test, or Fischer’s exact test, as
indicated in the ﬁgure legends. *P< 0.05, **P< 0.01, ***P< 0.001, n.s. indicates not
signiﬁcant. Error bars always indicate the standard error of the mean (SEM).
Image analysis. Quantitative analysis of immunohistochemistry or ﬂuorescent
ISH signals in the lesion site was performed on captured images. Samples were
ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/s41467-017-00143-0
14 NATURE COMMUNICATIONS |8:  126 |DOI: 10.1038/s41467-017-00143-0 |www.nature.com/naturecommunications
imaged using a compound ﬂuorescence microscope (Zeiss Imager.Z1) or confocal
microscope (Zeiss LSM 710, 880). Analysis of confocal images were performed on
maximum intensity projections that were generated from confocal stacks. Image
analysis was based on published protocols for ﬂuorescent signal quantiﬁcation70.
For all measurements except in Fig. 7b, ImageJ software was used to determine the
number of pixel above an intensity threshold (thresholded pixel area) in the region
of interest (ROI) (an example of such a measurement is shown in Supplementary
Fig. 14). In brief, a minimum intensity threshold was applied to all raw images
from the same dataset, limiting pixels to only those of equal or higher intensity.
The intensity threshold was determined for each experimental data set individually,
using untreated lesioned control samples as reference. The threshold was set such
that the thresholded pixel area included most pixels of the ﬂuorescence signal
domain in the lesion site while low background signal in the vicinity of the lesion
site was largely excluded (efﬁcient image segmentation). After thresholding, a ROI
was additionally deﬁned manually to exclude pixels from analysis that fell within
the threshold intensity range but were located outside the lesion site. This was
necessary in some samples to exclude autoﬂuorescence (e.g., from blood vessels)
or constitutively labelled domains (e.g., myosepta for Col XII). Measurements
of immunoreactivity in the lesion site, shown in Fig. 7b, was performed by
determining the pixel area in a pre-deﬁned ROI of constant size without prior
thresholding. This was necessary due to low signal to noise ratio. In brief, the image
was converted to a binary image using the automated binary thresholding function
of ImageJ. The ROI was placed in the center of the lesion site. All measurements
were performed in a blinded fashion.
In situ hybridization. All incubations were performed at room temperature unless
stated otherwise.
For chromogenic and Fast Red ﬂuorescence whole mount in situ hybridization
(ISH), larvae were ﬁxed overnight at 4 °C in 4% PFA-PBS. On the following
day, larvae were washed twice in PBT (0.1% Tween-20 in PBS) and incubated for
30 min in PBT containing 40 μg/ml Proteinase K (Invitrogen). Thereafter, larvae
were washed brieﬂy in PBT and were reﬁxed for 20 min in 4% PFA-PBS followed
by ﬁve washes in PBT for 5 min each. Thereafter, larvae were incubated at 65 °C for
> 1 h in pre-warmed hybridization buffer (5x SSC, 500 μg/ml type VI Torula yeast
RNA, 50 μg/ml Heparin, 0.1% Tween 20, 9 mM citric acid [Monohydrate]), 50%
deionized formamide, pH 6.0). Hybridization buffer was replaced with digoxigenin
(DIG) and/or ﬂuorescein-labelled ISH probes diluted in hybridization buffer and
incubated at 65 °C overnight. On the following day, larvae were washed at 65 °C
once in hybridization buffer, three times in 50% 2×SSCT/50% deionized
formamide, and twice in 2xSSCT for 20 min each, followed by four washes at 65 °C
in 0.2x SSCT (30x SSC: 300 mM NaCl, 200 mM Na-Citrate, pH 7; SSCT: 0.1 %
Tween 20 in 1xSSC) for 30 min each. Thereafter, larvae were washed twice in
PBT and incubated for > 1 h in blocking buffer (5% heat-inactivated sheep serum,
10 mg/ml BSA in PBT) for 5 min each under slow agitation. Subsequently, larvae
were incubated overnight at 4 °C in blocking buffer containing pre-absorbed anti-
DIG or anti-ﬂuorescein antibody coupled to alkaline phosphatase (1:3000–4000).
On the following day, larvae were washed six times in PBT for 20 min each,
followed by three washes in staining buffer (50 mMMgCl2, 100 mM NaCl, 100 mM
Tris-HCl, 0.1% Tween 20, pH 9.5) for 5 min each. Color reaction was performed by
incubating larvae in staining buffer supplemented with NBT/BCIP (Sigma-Aldrich)
or SIGMAFAST Fast Red (Sigma-Aldrich) substrate. The staining reaction was
terminated by washing larvae in PBT. For chromogenic ISH, background staining
was cleared by incubating larvae two times in 100% EtOH for 15 min each and
once in 50% EtOH-PBT for 5 min, followed by ﬁve washes in PBT for 5 min each.
TSA ﬂuorescence ISH was performed using the TSA Plus System Kit (Perkin
Elmer) as described for chromogenic ISH with some modiﬁcations. 1) Proteinase K
treatment was performed for 20 min (20 µg/ml Proteinase K). 2) Before pre-
hybridization, endogenous peroxidase activity was quenched by incubating larvae
in 1% H2O2 for 20 min. 3) Larvae were blocked in blocking reagent (1% in PBT)
provided with the kit. 4) Antibodies used to detect labelled RNA hybrids were anti-
digoxigenin or anti-ﬂuorescein antibodies coupled to peroxidase (1:500). 5) Color
reaction was performed for 30 min in ampliﬁcation buffer containing Tyramid
substrate (1:500) provided with the Kit, followed by washes in PBT for 20 min each.
Simultaneous detection of two different mRNAs by ISH was performed using
two-color TSA ﬂuorescence or combinations of Fast Red and TSA ﬂuorescence.
Stained samples (Fast Red and TSA ﬂuorescence) were embedded in 4% Agarose-
PBS and sectioned at 50–100 µm using a vibratome. Sections were stained for DAPI
(Thermo Scientiﬁc) to visualize nuclei, followed by two washes in PBS and
mounted in 75% Glycerol-PBS. Larvae were incubated for 30 min in 2% H2O2 after
the ﬁrst color reaction to deactivate antibody-conjugated peroxidase.
For Fast Red ﬂuorescent ISH on ﬂoating agarose sections of larval zebraﬁsh,
larvae were ﬁxed in 4% PFA-PBS at 4 °C overnight. After two brief washes in PBT
(0.1% Tween-20 in PBS), larvae were embedded in 4% Agarose-PBS and sectioned
at 50–100 µm using a vibratome. Sections were incubated for 20 min in PBT
containing 10 μg/ml Proteinase K (Invitrogen) and further processed as described
for whole mount preparations.
For Fast Red ﬂuorescent ISH on ﬂoating agarose sections of adult zebraﬁsh
tissue, zebraﬁsh were transcardially perfused with PBS followed by ﬁxative
(4% PFA). The lesion site with surrounding non-neural tissue and spinal cord was
dissected in a semi-intact preparation and the tissue was post-ﬁxed in 4% PFA
overnight. Tissue was embedded in 4% Agarose-PBS and sectioned at 100–200 µm
using a vibratome. Sections were brieﬂy rinsed in PBS, incubated for 30 min in
PBT containing 40 μg/ml Proteinase K (Invitrogen) and further processed as
described for whole mount preparations.
To detect gfp transcripts in 6xTCF:dGFP;hs:Axin1-YFP double transgenic larvae
we used a probe against the destabilizing signal (sequence coding for residues
422–461 of mouse ornithine decarboxylase [MODC] as reported previously25.
To detect cerulean transcripts in hs:col12a1a-p2a-Cerulean transgenic ﬁsh we
used a probe against the closely sequence-related gfp as described previously25.
Information on ISH probes, including primer sequences used for molecular
cloning, is provided in the Supplementary Data 1. Where possible, probes to detect
collagen chains-coding transcripts were designed to include 3′UTR, which in most
cases contained sequences with the lowest possible similarity to other collagen
genes. During the ISH screen only genes were considered detectably expressed for
which probes showed a signal in the lesion site within 8 h after initiation of staining
reaction. Functionality of probes that showed no staining in the lesion site was
veriﬁed by the presence of speciﬁc staining domains in non-lesion site tissue, which
was true for all probes except col4a4, col8a1b, and col16a1, which did not show
constitutive expression domains in 4 dpf larvae. Lesion-induced upregulation of
genes in the lesion site was determined by comparing the signal intensity in the
lesion site to that in adjacent unlesioned trunk tissue.
Immunoﬂuorescence. All incubations were performed at room temperature unless
stated otherwise.
For whole mount acetylated Tubulin/GFAP immunolabeling, larvae were ﬁxed
in 2% TCA-PBTx (1% Triton X-100 in PBS) for 3 h, followed by brief washes in
PBTx and PBS. Thereafter, larvae were incubated for 30 min in 0.25% Trypsin
(Gibco) diluted in PBS, followed by ﬁve washes in PBTx for 5 min each. Larvae
were blocked in 4% BSA-PBTx for 1 h and incubated with primary antibody
(1:300) diluted in blocking buffer at 4 °C overnight. On the following day, larvae
were washed six times in PBTx for 20 min each, followed by incubation with
secondary antibody of interest diluted in blocking buffer (1:300) at 4 °C overnight.
On the following day, larvae were washed six times each in PBTx for 20 min each,
followed by mounting in PBS or 75% Glycerol-PBS.
For whole mount GFP/acetylated Tubulin/p63 immunolabelling in 6xTCF:
dGFP transgenic larvae, larvae were ﬁxed in 4% PFA-PBS containing 1% DMSO at
4 °C overnight. On the following day, larvae were washed four times in PBS,
followed by two washes in PBTx (0.2% Triton X-100 in PBS) for 5 min each.
Thereafter, larvae were permeabilized by incubation in PBS containing 2 mg/ml
Collagenase (Sigma-Aldrich) for 25 min. To terminate Collagenase digest, larvae
were brieﬂy rinsed in PBTx. Subsequently, larvae were incubated in 50 mM glycine
in PBTx for 10 min, followed by a brief rinse in PBTx. Larvae were blocked
in blocking buffer (0.7% PBTx, 1% DMSO, 1% normal donkey serum, 1% BSA)
for 2 h, and incubated with primary antibody (1:300–1:500) diluted in blocking
buffer at 4 °C overnight. On the following day, larvae were washed three times in
PBTx for 15 min each, followed by incubation with secondary antibody of interest
diluted in blocking buffer (1:300) at 4 °C overnight. On the following day, larvae
were washed three times in PBTx and once in PBS for 15 min each, before
mounting in 75% Glycerol-PBS.
For whole mount acetylated Tubulin/GFAP immunolabelling, as well as all
other combinations of immunolabelling on whole mounts (e.g., acetylated Tubulin/
Col XII), larvae were ﬁxed in 4% PFA-PBS for 1 h, followed by brief washes in 0.1%
PBT (0.1% Tween-20 in PBS). Thereafter, larvae were stepwise dehydrated by
successive incubation in 25% MeOH-PBT, 50% MeOH-PBT, 75% MeOH-PBT,
100% MeOH for 5 min each, and stored at −20 °C until need. When required, head
and tail of larvae were removed and lesion site-enriched trunk tissue was incubated
in 100% MeOH at −20 °C overnight. On the following day, samples were
rehydrated by successive incubations in 75% MeOH-PBT, 50% MeOH-PBT and
25% MeOH-PBT for 5 min each, followed by four washes each in PBT for 5 min
each. Larvae were washed twice in distilled H2O for 5 min each, followed by
incubation in 100% Acetone (pre-chilled to −20 °C) at −20 °C for 10 min.
Thereafter, larvae were washed twice in distilled H2O for 5 min each, followed by
two 5min washes in PBT. Subsequently, larvae were incubated in PBT containing
10 µg/ml Proteinase K (Invitrogen) for 15 min, followed by two brief washes in
PBT and re-ﬁxation in 4% PFA-PBS for 15 min. Thereafter, larvae were washed
tree times in PBTx (1% Triton X-100 in PBS) 10 min each and incubated in
blocking buffer (4% BSA in PBTx) for 1 h. Thereafter, larvae were incubated with
primary antibody (1:300) diluted in blocking buffer at 4 °C for 2–3 days. Thereafter,
larvae were washed eight times in PBTx for 20 min each, followed by incubation
with secondary antibody of interest diluted in blocking buffer (1:300) at 4 °C for
1–2 days. Thereafter, larvae were washed six times in PBTx for 20 min each and
once in PBS for 15 min before mounting in 75% Glycerol-PBS.
For immunohistochemistry on ﬂoating agarose sections of larval zebraﬁsh,
larvae were ﬁxed in 4% PFA-PBS containing 1% DMSO at 4 °C overnight.
After two brief washes in PBT (0.1% Tween-20 in PBS), larvae were embedded
in 4% Agarose-PBS and sectioned at 50–100 µm using a vibratome. Sections were
brieﬂy rinsed in PBS and incubated in PBS containing 2 mg/ml Collagenase
(Sigma-Aldrich) for 20 min. Thereafter, sections were washed several times in
PBTx (0.5% Triton X-100 in PBS) followed by incubation in blocking buffer
(0.7% PBTx, 1% DMSO, 1% normal donkey serum, 1% BSA) for 1 h, and incubated
with primary antibody (1:50–1:200) diluted in blocking buffer at 4 °C for 2–3 days.
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Thereafter, sections were washed eight times in PBTx for 20 min each, followed
by incubation with secondary antibody of interest diluted in blocking buffer (1:300)
at 4 °C overnight. On the following day, larvae were washed six times in PBTx
and twice in PBS for 20 min each. Sections were stained for DAPI (Thermo
Scientiﬁc) to visualize nuclei, followed by two washes in PBS and mounted in
75% Glycerol-PBS.
For immunohistochemistry on ﬂoating agarose sections of adult zebraﬁsh
tissue, zebraﬁsh were transcardially perfused with PBS followed by ﬁxative
(4% PFA-PBS). The lesion site with surrounding non-neural tissue and spinal cord
was dissected in a semi-intact preparation and the tissue was post-ﬁxed in 4% PFA
for 1 h. Tissue was embedded in 4% Agarose-PBS and sectioned at 100–200 µm
using a vibratome. Sections were brieﬂy rinsed in PBS and washed several times in
PBTx (1% Triton X-100 in PBS) for a total of 1 h followed by incubation in
blocking buffer (4% BSA in PBTx). Thereafter, sections were incubated with
primary antibody (1:250) diluted in blocking buffer at 4 °C for 3 days. Thereafter,
sections were washed eighteen times in PBTx for 10 min each, followed by
incubation with secondary antibody of interest diluted in blocking buffer (1:250)
at 4 °C for 2 days. On the following day, sections were washed twelve times in PBTx
and twice in PBS for 20 min each. Sections were mounted in 75% Glycerol-PBS.
All primary antibodies used are given in Supplementary Table 3. Primary
antibodies used are speciﬁc for zebraﬁsh antigens as shown in the indicated
publications. To detect basal keratinocytes, we used anti-p63
immunohistochemistry, which is a commonly used marker for this cell lineage37.
The antibody used in this study, anti-tp63 antibody (Sigma-Aldrich), replicates
selective labelling of monolayered basal keratinocytes found in previous
publications with other antibodies to this antigen. Secondary ﬂuorophore-
conjugated antibodies were from Jackson Immuno Research.
Data availability. The authors declare that all data supporting the ﬁndings of this
study are available within the article and its supplementary information ﬁles, or
from the corresponding authors on reasonable request.
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